Japan’s Astellas Pharma Inc is set to acquire Audentes Therapeutics Inc for around $3 billion in a deal aimed at boosting genetic medicines – a key area of growth. Gene therapies are one of the hottest areas of drug research…. Read More ›
gene therapies
Pfizer Inc to acquire Array Biopharma Inc for $10.64 billion
The deal will not only add to Pfizer’s EPS, but will also provide to stronger traction in the cancer drugs market. U.S. pharmaceutical giant Pfizer Inc stated it would acquire Array Biopharma Inc for $10.64 billion in cash. The potential… Read More ›
manageria.biz 